trial · primary record
Bepirovirsen
Hepatitis B
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 98 |
| Primary completion | 2027-03-30 |
| Primary endpoint | Area Under the Concentration-time Curve from Time Zero (pre-dose) up to Day 8 [AUC(0- 8 d)] of Bepirovirsen in Plasma |
| Registry ID | NCT07905157 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:35.423Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07905157
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- BEPIROVIRSEN · approval
- Bepirovirsen · compound